MD One Ventures And Randox Launch National Security And Biotech Accelerator

The program provides early-stage companies with funding and hands-on support to accelerate growth. Focused on strengthening national resilience, it develops technologies shaping the future of UK and allied security and healthcare.

By fast-tracking real-world solutions, the incubator ensures the next generation of breakthrough capabilities is built, tested, and deployed faster than traditional systems allow.

The MD One Ventures team features Co-founder Will McManners, a former British Army officer with 10 years of service in Specialist Military Units, including Commando and JTAC roles, before transitioning to BlackRock, Investbridge Capital, and Palantir.

Read Also - London-Based Iconic Raises €11 Million To Develop On-Device AI Platform For Next-Gen Gaming

Supporting him is Cecilia Fortugno, PhD, Vice President and Chief Operations Officer at Randox Biosciences, who also serves as Senior Technical Advisor for the accelerator, providing strategic guidance.

Wil McManners, Co-founder of MD One Ventures, commented: "This is not a traditional accelerator, it's a strategic partnership designed to de-risk and accelerate companies that solve national security and public health challenges.

The access our founders receive to Randox's infrastructure is literally a money can't buy opportunity.

We are looking to support world-class founding teams that can deliver solutions to fundamental issues affecting our National Infrastructure, Health and ultimately, Security".

Dr Cecilia Fortugno, Vice President and Chief Operations Officer at Randox Biosciences and the Senior Technical Advisor for Randox for Builders, said:

"For forty years, Randox has invested deeply in R&D to drive diagnostic and preventative healthcare. This program with MD Ones is a natural extension of that mission.

By opening our technical infrastructure to the next generation of innovators, we are ensuring that the solutions to future health and security challenges are being built and scaled rapidly right now."

The incubator has begun investing, with early portfolio companies including Untap Health which offers automated wastewater-based diagnostics, and Airfinity, a health intelligence and bio-risk forecasting platform leveraging AI-driven simulations.